Accuracy of the dexamethasone suppression test for the prediction of autonomous cortisol secretion-related comorbidities in adrenal incidentalomas

CONCLUSIONS: The DST is a poor predictor of cardiometabolic comorbidities in patients with AIs regardless of the cortisol cut-off values applied. This finding suggests that the diagnosis of ACS should not be based solely on the results of the DST. Other clinical, metabolic, or imaging markers showing a better performance for the prediction of the development and progression of cardiometabolic comorbidities in AIs need to be identified.PMID:34273083 | DOI:10.1007/s42000-021-00308-z

Source: Hormones - July 17, 2021 Category: Endocrinology Authors: Marta Araujo-Castro Paola Parra Ram írez Cristina Robles L ázaro Rogelio Garc ía Centeno Paola Gracia Gimeno Mariana Tom é Fernández-Ladreda Miguel Antonio Sampedro N úñez M ónica Marazuela H éctor F Escobar-Morreale Pablo Valderrabano Source Type: research